Vaccine link to thyroid disease under investigation
NCT ID NCT07213141
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether COVID-19 vaccination might trigger Graves' disease, a condition where the immune system attacks the thyroid. Researchers will review medical records of 161 people who developed Graves' disease for the first time between March 2020 and October 2022. They want to see if cases that happened shortly after vaccination are different from typical cases, which could help doctors better diagnose and treat the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAVES' DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Brugmann
Brussels, 1020, Belgium
-
CHU St Pierre
Brussels, 1000, Belgium
-
UZ Brussel
Jette, 1090, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Targeting the immune system: a new antibody may free Graves' patients from daily drugs
- AI reads eye scans to spot thyroid disease activity and severity
- New drug aims to tame overactive thyroid in Graves' disease
- New drug aims to tame overactive thyroid in Graves' disease
- Smartwatch AI could spot dangerous thyroid Flare-Ups
- Hidden thyroid cancers: how common are they in patients with thyroiditis?